Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P

Toshiharu Azma, Yuki Sugimoto, Hiroyuki Kinoshita, Taishin Ito, Masanori Tsukamoto, Hiroshi Hoshijima, Masakazu Nakao, Hirosato Kikuchi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We have recently reported that a neurotransmitter for pain, substance-P (SP), promotes plateletdependent clot formation through neurokinin-1 receptors (NK1Rs), in which leukocytes appear to be involved (J Thromb Thrombolysis 2009;27:280-6). Two naturally occurring splice isoforms of NK1R with different signal transduction potency, namely the full-length and the truncated NK1Rs are identified. It is known that human leukocytes express truncated NK1Rs, while in vivo expression of the full-length NK1R has not yet been fully clarified. Modulatory effects of alternative splicing for NK1Rs on clot formation also remain to be evaluated. Expression of the transcript variant mRNA for NK1Rs in human whole blood (n = 20) was evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR). A 15 min time series of the strength of clot, formed after reloading of calcium in citrated whole blood with or without SP (10 nM) and a NK1R antagonist Spantide (1 lM), was measured by using oscillating-probe viscoelastometry. The full-length transcript variant was detected in 5 samples among 20. SP significantly increased the clot strength while Spantide suppressed the SP-derived change. The extent of modulation by SP/NK1R pathway in a subgroup with expression of the full-length transcript variant was three times as potent as those in another subgroup without expression. We conclude that expression of the full-length transcript variant for NK1R can be detected in human whole blood and that such expression is associated with the enhanced reinforcement of clot by SP. Further study is required to nominate this mRNA as a biomarker for prothrombotic risks in painful conditions such as perioperative period.

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalJournal of Thrombosis and Thrombolysis
Volume33
Issue number4
DOIs
Publication statusPublished - May 1 2012
Externally publishedYes

Fingerprint

Neurokinin-1 Receptors
Substance P
Leukocytes
Neurokinin-1 Receptor Antagonists
Reinforcement (Psychology)
Messenger RNA
Perioperative Period
Alternative Splicing
Reverse Transcription
Neurotransmitter Agents
Signal Transduction
Protein Isoforms
Biomarkers
Calcium
Pain
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P. / Azma, Toshiharu; Sugimoto, Yuki; Kinoshita, Hiroyuki; Ito, Taishin; Tsukamoto, Masanori; Hoshijima, Hiroshi; Nakao, Masakazu; Kikuchi, Hirosato.

In: Journal of Thrombosis and Thrombolysis, Vol. 33, No. 4, 01.05.2012, p. 329-337.

Research output: Contribution to journalArticle

Azma, Toshiharu ; Sugimoto, Yuki ; Kinoshita, Hiroyuki ; Ito, Taishin ; Tsukamoto, Masanori ; Hoshijima, Hiroshi ; Nakao, Masakazu ; Kikuchi, Hirosato. / Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P. In: Journal of Thrombosis and Thrombolysis. 2012 ; Vol. 33, No. 4. pp. 329-337.
@article{7f468934124642969d9de5b718922827,
title = "Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P",
abstract = "We have recently reported that a neurotransmitter for pain, substance-P (SP), promotes plateletdependent clot formation through neurokinin-1 receptors (NK1Rs), in which leukocytes appear to be involved (J Thromb Thrombolysis 2009;27:280-6). Two naturally occurring splice isoforms of NK1R with different signal transduction potency, namely the full-length and the truncated NK1Rs are identified. It is known that human leukocytes express truncated NK1Rs, while in vivo expression of the full-length NK1R has not yet been fully clarified. Modulatory effects of alternative splicing for NK1Rs on clot formation also remain to be evaluated. Expression of the transcript variant mRNA for NK1Rs in human whole blood (n = 20) was evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR). A 15 min time series of the strength of clot, formed after reloading of calcium in citrated whole blood with or without SP (10 nM) and a NK1R antagonist Spantide (1 lM), was measured by using oscillating-probe viscoelastometry. The full-length transcript variant was detected in 5 samples among 20. SP significantly increased the clot strength while Spantide suppressed the SP-derived change. The extent of modulation by SP/NK1R pathway in a subgroup with expression of the full-length transcript variant was three times as potent as those in another subgroup without expression. We conclude that expression of the full-length transcript variant for NK1R can be detected in human whole blood and that such expression is associated with the enhanced reinforcement of clot by SP. Further study is required to nominate this mRNA as a biomarker for prothrombotic risks in painful conditions such as perioperative period.",
author = "Toshiharu Azma and Yuki Sugimoto and Hiroyuki Kinoshita and Taishin Ito and Masanori Tsukamoto and Hiroshi Hoshijima and Masakazu Nakao and Hirosato Kikuchi",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/s11239-011-0650-1",
language = "English",
volume = "33",
pages = "329--337",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P

AU - Azma, Toshiharu

AU - Sugimoto, Yuki

AU - Kinoshita, Hiroyuki

AU - Ito, Taishin

AU - Tsukamoto, Masanori

AU - Hoshijima, Hiroshi

AU - Nakao, Masakazu

AU - Kikuchi, Hirosato

PY - 2012/5/1

Y1 - 2012/5/1

N2 - We have recently reported that a neurotransmitter for pain, substance-P (SP), promotes plateletdependent clot formation through neurokinin-1 receptors (NK1Rs), in which leukocytes appear to be involved (J Thromb Thrombolysis 2009;27:280-6). Two naturally occurring splice isoforms of NK1R with different signal transduction potency, namely the full-length and the truncated NK1Rs are identified. It is known that human leukocytes express truncated NK1Rs, while in vivo expression of the full-length NK1R has not yet been fully clarified. Modulatory effects of alternative splicing for NK1Rs on clot formation also remain to be evaluated. Expression of the transcript variant mRNA for NK1Rs in human whole blood (n = 20) was evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR). A 15 min time series of the strength of clot, formed after reloading of calcium in citrated whole blood with or without SP (10 nM) and a NK1R antagonist Spantide (1 lM), was measured by using oscillating-probe viscoelastometry. The full-length transcript variant was detected in 5 samples among 20. SP significantly increased the clot strength while Spantide suppressed the SP-derived change. The extent of modulation by SP/NK1R pathway in a subgroup with expression of the full-length transcript variant was three times as potent as those in another subgroup without expression. We conclude that expression of the full-length transcript variant for NK1R can be detected in human whole blood and that such expression is associated with the enhanced reinforcement of clot by SP. Further study is required to nominate this mRNA as a biomarker for prothrombotic risks in painful conditions such as perioperative period.

AB - We have recently reported that a neurotransmitter for pain, substance-P (SP), promotes plateletdependent clot formation through neurokinin-1 receptors (NK1Rs), in which leukocytes appear to be involved (J Thromb Thrombolysis 2009;27:280-6). Two naturally occurring splice isoforms of NK1R with different signal transduction potency, namely the full-length and the truncated NK1Rs are identified. It is known that human leukocytes express truncated NK1Rs, while in vivo expression of the full-length NK1R has not yet been fully clarified. Modulatory effects of alternative splicing for NK1Rs on clot formation also remain to be evaluated. Expression of the transcript variant mRNA for NK1Rs in human whole blood (n = 20) was evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR). A 15 min time series of the strength of clot, formed after reloading of calcium in citrated whole blood with or without SP (10 nM) and a NK1R antagonist Spantide (1 lM), was measured by using oscillating-probe viscoelastometry. The full-length transcript variant was detected in 5 samples among 20. SP significantly increased the clot strength while Spantide suppressed the SP-derived change. The extent of modulation by SP/NK1R pathway in a subgroup with expression of the full-length transcript variant was three times as potent as those in another subgroup without expression. We conclude that expression of the full-length transcript variant for NK1R can be detected in human whole blood and that such expression is associated with the enhanced reinforcement of clot by SP. Further study is required to nominate this mRNA as a biomarker for prothrombotic risks in painful conditions such as perioperative period.

UR - http://www.scopus.com/inward/record.url?scp=84865152461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865152461&partnerID=8YFLogxK

U2 - 10.1007/s11239-011-0650-1

DO - 10.1007/s11239-011-0650-1

M3 - Article

VL - 33

SP - 329

EP - 337

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 4

ER -